CD300ld blockade overcomes PMN-MDSC-mediated vaccine resistance in advanced tumors

Background While cancer vaccines have demonstrated promising clinical potential, their therapeutic efficacy against advanced tumors remains suboptimal, highlighting the critical need to elucidate resistance mechanisms and develop targeted solutions. We previously developed a stimulator of interferon...

Descripció completa

Dades bibliogràfiques

Autors principals:	Miaomiao Yang, Min Luo, Mengyan Wang, Yuwei Li, Zhigang Lu, Xianglei Wang, Shiyao Xue, Haotian Yu, Suxin Li
Format:	Artigo
Idioma:	Inglês
Publicat:	BMJ Publishing Group 2026-01-01
Col·lecció:	Journal for ImmunoTherapy of Cancer
Accés en línia:	https://jitc.bmj.com/content/14/1/e013336.full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!